Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Netherton syndrome is a genetic condition that can result in abnormal skin functioning.
People with this condition often have red and scaling skin; sparse or short hair; and
problems with absorption of medicines or chemicals that are applied to the skin. If these
chemicals are absorbed at a high level, they may cause health problems. Elidel (pimecrolimus)
is a new medicine that is available as a cream. It has been shown to help improve the
appearance of the skin in patients with another skin condition known as atopic dermatitis,
and is approved by the United States (US) Food and Drug Administration for use in children
with mild to moderate atopic dermatitis. The purpose of this study is to determine if Elidel
is safe, to see whether the medication is absorbed through the skin, and to see if side
effects are associated with its use in children with Netherton syndrome.